The rise of antibiotic resistance
A UK government review in 2015 estimated that by 2050, the global cost of antibiotic resistance will rise to US$100 trillion and drug-resistant infections will cause ten million deaths a year, eclipsing the current toll from cancer and diabetes combined.
In the UK alone, the government estimates there are currently 5,000 deaths each year because antibiotics no longer work for some infections.
There have been no new antibiotics introduced into clinical use for 30 years, and those in use are increasingly found to be less and less effective.
Led by Professor Mathew Upton, Professor in Medical Microbiology, researchers at the University of Plymouth's Antibiotic resistant pathogens research group have pioneered a drug discovery programme focused on identifying the next generation of antibiotics, helping meet the need for novel approaches to the threat of antimicrobial resistance.